Get started

Financials · SIBN

SI-BONE Inc. (SIBN) financials

For the twelve months ended Sep 30, 2026, SI-BONE Inc. reported $220.65M of revenue and -$13.69M of net income.

Revenue, TTM
$220.65M
Revenue growth, YoY
+14.0%
Net income, TTM
-$13.69M
Net margin
-6.2%
Free cash flow, TTM
-$4.19M
EPS, diluted, TTM
-$0.31
Cash
$35.31M
Total debt
$35.66M
P/S
5.23
Market cap
$1.15B
Annual revenue$200.93M
FY2017FY2025
Annual net income-$18.90M
FY2017FY2025
Annual free cash flow-$9.09M
FY2017FY2025

SIBN revenue and earnings growth

SIBN revenueQ3 2026$55.70M

Quarter YoY
+14.5%
QoQ
-0.5%
FY YoY
+20.2%
5Y CAGR
+22.3%

SIBN revenue was $55.70M in fiscal Q3 2026 (ended Sep 30, 2026), up 14.5% from a year earlier and down 0.5% from the prior quarter. For the full fiscal 2025 it was $200.93M, up 20.2% from fiscal 2024. Compound annual growth was +22.3% over 5 years. It rose in each of the last 8 fiscal years. Fiscal 2025 is the highest of the 9 fiscal years on file.

SIBN net incomeQ3 2026-$3.62M

SIBN net income was -$3.62M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$4.57M a year earlier. For the full fiscal 2025 it was -$18.90M, compared with -$30.91M in fiscal 2024.

SIBN EPSQ3 2026-$0.08

SIBN diluted EPS was -$0.08 in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$0.11 a year earlier. For the full fiscal 2025 it was -$0.44, compared with -$0.75 in fiscal 2024.

SIBN free cash flowQ3 2026-$427.0K

SIBN free cash flow was -$427.0K in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$620.0K a year earlier. For the full fiscal 2025 it was -$9.09M, compared with -$22.92M in fiscal 2024.

Export CSV

Income statement

Income statement
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
Revenue$200.93M$167.18M$138.89M$106.41M$90.15M$73.39M$67.30M$55.38M$47.98M
Cost of revenue$41.05M$35.06M$29.47M$15.71M$10.43M$8.90M$6.79M$4.83M$5.11M
Gross profit$159.88M$132.12M$109.42M$90.70M$79.72M$64.48M$60.51M$50.55M$42.87M
Research and development$17.45M$16.56M$15.03M$13.63M$12.44M$9.46M$7.28M$5.38M$5.51M
Selling, general and admin$40.54M$33.76M$31.07M$28.96M$25.07M$19.80M$20.98M$12.64M$13.06M
Operating income-$22.33M-$35.25M-$46.93M-$59.61M-$51.67M-$38.57M-$36.00M-$11.96M-$17.35M
Interest expense$2.63M$3.44M$3.46M$2.82M$5.37M$6.10M$4.95M$5.11M$6.20M
Pre-tax income------$43.70M-$38.40M-$17.45M-$23.04M
Income tax$0$0$0$0$0--$0$0
Net income-$18.90M-$30.91M-$43.34M-$61.26M-$56.57M-$43.70M-$38.40M-$17.45M-$23.04M
EPS, basic-$0.44-$0.75-$1.13-$1.79-$1.71-$1.50-$1.55-$2.20-$6.65
EPS, diluted-$0.44-$0.75-$1.13-$1.79-$1.71-$1.50-$1.55-$2.20-$6.65
Diluted shares43.0M41.5M38.4M34.2M33.1M29.1M24.7M8.0M3.5M

Balance sheet

Balance sheet
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
Cash and equivalents$42.24M$34.95M$33.27M$20.72M$63.42M$53.58M$10.44M$25.12M$22.41M
Receivables$29.91M$27.46M$21.95M$20.67M$14.25M$13.61M$11.72M$8.49M$7.42M
Inventory$33.90M$27.07M$20.25M$17.28M$11.50M$5.63M$5.45M$3.34M$2.55M
Current assets$216.12M$207.78M$211.39M$137.61M$175.87M$218.24M$111.46M$136.04M$33.63M
Total assets$238.56M$230.44M$230.43M$157.55M$190.51M$223.14M$117.01M$138.52M$35.83M
Current liabilities$25.28M$27.13M$23.46M$21.18M$16.89M$13.47M$18.77M$9.01M$7.54M
Short-term debt----$0$0$4.36M$0-
Long-term debt$35.57M$35.45M$36.06M$35.17M$34.97M$39.45M$34.87M$38.96M$38.70M
Total debt$35.57M$35.45M$36.06M$35.17M$34.97M$39.45M$39.22M$38.96M$38.70M
Total liabilities$61.02M$63.47M$61.05M$59.25M$56.09M$53.78M$54.00M$48.33M$46.66M
Shareholders' equity$177.53M$166.96M$169.38M$98.30M$134.42M$169.36M$63.01M$90.19M-$129.38M

Cash flow

Cash flow
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
Operating cash flow-$675.0K-$12.43M-$18.71M-$41.66M-$39.53M-$30.66M-$31.63M-$14.52M-$17.53M
Capital expenditures$8.41M$10.50M$7.80M$9.51M$6.39M$2.56M$2.44M$942.0K$478.0K
Free cash flow-$9.09M-$22.92M-$26.51M-$51.16M-$45.92M-$33.22M-$34.07M-$15.46M-$18.01M
Investing cash flow$4.16M$12.62M-$59.80M-$2.81M$51.58M-$62.92M$13.49M-$97.83M-$478.0K
Financing cash flow$3.38M$1.96M$90.93M$2.20M-$1.71M$136.40M$3.49M$115.15M$12.86M
Share repurchases------$38.0K$73.0K$0
Stock-based compensation$25.52M$25.87M$24.06M$23.06M$16.87M$11.93M$7.46M$2.31M$1.44M
Depreciation and amortization$5.77M$4.38M$5.43M$3.45M$2.09M$1.13M$774.0K$722.0K$1.01M

Key ratios

Key ratios
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
Revenue growth, YoY20.2%20.4%30.5%18.0%22.8%9.0%21.5%15.4%-
Gross margin79.6%79.0%78.8%85.2%88.4%87.9%89.9%91.3%89.3%
Operating margin-11.1%-21.1%-33.8%-56.0%-57.3%-52.6%-53.5%-21.6%-36.2%
Net margin-9.4%-18.5%-31.2%-57.6%-62.8%-59.5%-57.1%-31.5%-48.0%
Free cash flow margin-4.5%-13.7%-19.1%-48.1%-50.9%-45.3%-50.6%-27.9%-37.5%
Return on equity-10.6%-18.5%-25.6%-62.3%-42.1%-25.8%-60.9%-19.4%-
Return on assets-7.9%-13.4%-18.8%-38.9%-29.7%-19.6%-32.8%-12.6%-64.3%
Current ratio8.557.669.016.5010.4116.205.9415.114.46
Debt to equity0.200.210.210.360.260.230.620.43-

Source: XBRL data SI-BONE Inc. files with the SEC, latest filing dated Nov 3, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

SIBN peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
SIBN$220.65M+14.0%-$13.69M-6.2%$1.15B
SYK$26.30B+7.9%$3.62B13.8%$124.00B
MMM$25.25B+1.7%$3.54B14.0%$97.47B
BSX$21.07B+8.9%$3.50B16.6%$63.81B
BDX$23.25B+17.4%$941.00M4.0%$58.63B
MDLN$30.68B-$683.00M2.2%$53.55B
RMD$5.73B+9.0%$1.59B27.8%$33.16B
DXCM$5.10B+13.0%$991.00M19.4%$30.24B
WST$3.40B+12.6%$638.90M18.8%$28.78B

SIBN FAQ

9 questions
  • What is SIBN revenue?
    SI-BONE Inc. (SIBN) reported $220.65M of revenue for the twelve months ended Sep 30, 2026. That is up 14.0% from the year before. Revenue for fiscal 2025 was $200.93M.
  • Is SIBN profitable?
    No. SI-BONE Inc. reported a net loss of $13.69M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does SIBN have?
    SI-BONE Inc. reported $35.31M in cash and cash equivalents and $35.66M of debt on its most recent balance sheet in SEC filings.
  • How fast is SIBN revenue growing?
    SI-BONE Inc.'s revenue changed +20.2% in fiscal 2025, to $200.93M. Its compound annual growth rate was +22.3% over 5 years.
  • What is SIBN gross margin?
    SI-BONE Inc.'s gross profit was $175.19M on $220.65M of revenue for the twelve months ended Sep 30, 2026, a gross margin of 79.4%.
  • What is SIBN free cash flow?
    SI-BONE Inc. generated -$4.19M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $6.08M less capital expenditures.
  • What is SIBN earnings per share?
    Diluted earnings per share were -$0.31 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did SIBN last report financial results?
    The latest statements here come from SI-BONE Inc.'s 10-Q filed on Nov 3, 2026, covering the period ended Sep 30, 2026.
  • Where does this SIBN financial data come from?
    Quantisnow builds these statements from the structured XBRL data SI-BONE Inc. files with the SEC. It is provided for information only and is not investment advice.